Page last updated: 2024-09-03

imatinib mesylate and Appendiceal Cancer

imatinib mesylate has been researched along with Appendiceal Cancer in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (33.33)29.6817
2010's2 (66.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hamaguchi, H; Iwanaga, T; Katsumori, T; Ohkawara, S; Oshima, H; Tsukamoto, Y; Yamamoto, S1
Abu-Gazala, M; Almogy, G; Appelbaum, L; Bala, M; Elazary, R; Khalaileh, A; Khatib, A; Neuman, T; Rivkind, AI; Schlager, A1
Chander, S; Lay Ergun, E; Shields, AF1

Reviews

1 review(s) available for imatinib mesylate and Appendiceal Cancer

ArticleYear
Malignant appendiceal GIST: case report and review of the literature.
    Journal of gastrointestinal cancer, 2010, Volume: 41, Issue:1

    Topics: Abscess; Antineoplastic Agents; Appendiceal Neoplasms; Benzamides; Diabetes Mellitus, Type 2; Gastrointestinal Stromal Tumors; Humans; Hypertension; Imatinib Mesylate; Immunohistochemistry; Male; Middle Aged; Neoadjuvant Therapy; Piperazines; Pyrimidines; Tomography, X-Ray Computed

2010

Other Studies

2 other study(ies) available for imatinib mesylate and Appendiceal Cancer

ArticleYear
[A Case of Small Intestinal Gastrointestinal Stromal Tumor(GIST)with Synchronous Colonic Cancer and Gastric Cancer at a Different Time].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2016, Volume: 43, Issue:12

    Topics: Adenocarcinoma; Aged; Antineoplastic Agents; Appendiceal Neoplasms; Female; Gastrointestinal Stromal Tumors; Humans; Ileal Neoplasms; Imatinib Mesylate; Neoplasms, Multiple Primary; Stomach Neoplasms; Treatment Outcome

2016
An FDG positron emission tomographic study in a case of gastrointestinal stromal tumor.
    Clinical nuclear medicine, 2003, Volume: 28, Issue:4

    Topics: Appendiceal Neoplasms; Benzamides; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Gastrointestinal Neoplasms; Humans; Imatinib Mesylate; Jejunal Neoplasms; Middle Aged; Neoplasm Recurrence, Local; Piperazines; Pyrimidines; Radionuclide Imaging; Radiopharmaceuticals; Treatment Outcome

2003